- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03921853
Resistance Training in Patients With Morbid Obesity (ExinMO)
Preventing Metabolic Syndrome in Patients With Morbid Obesity by Resistance Training: Reporting Non-responder Prevalence
Study Overview
Status
Intervention / Treatment
Detailed Description
The prevalence of metabolic syndrome (MetS) and cardiovascular disease is expected to rise along with the global obesity epidemic. MetS is a cluster of clinical risk factors, including abdominal (visceral) obesity, hypertension, elevated serum triglycerides, low serum high-density lipoprotein (HDL) and hyperglycaemia.The MetS for example, significantly decreases the life expectancy of individuals with morbid obesity and increases the disease burden and economic costs associated with healthcare. In this sense, more recently, there was reported that body mass index (BMI) and fat distribution showed higher associations with inflammation, fat indices, and more prevalence of MetS in morbidly obese subjects, claiming for an early prevention of the MetS in the morbid obese state.
Exercise training has proven to be effective in inducing a clinically significant weight loss and reducing cardiovascular risk. Exercise have reported to be associated with increased muscle mass, decreased body fat, and improved metabolic profile (i.e., improved glucose control and lipid levels). In addition, supervised RT improved muscle strength and functional capacity in patients with obesity undergoing bariatric surgery. However, although RT has been widely studied in obesity, there is little information in the morbid obesity. On the other hand, there is poor knowledge similarly, about the interindividual variability to exercise training in terms of responders and non-responders (NR). Thus, considering the poor knowledge about the MetS prevention in morbid obese patients, as well as the little information about Responders and Non-Responders for improving MetS outcomes, the aim of this study will be determine the effects of a RT program on cardio-metabolic outcomes of MetS in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of the effects of resistance training on MetS markers and other health-related variables.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Llanquihue
-
Osorno, Llanquihue, Chile, 5290000
- Cristian ALvarez
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion Criteria:
- Older than 18 and younger and ≤65 years of age.
- With risk factors to Metabolic syndrome
- With obesity and morbid obesity condition
- Medical authorization by a physician.
Exclusion Criteria:
- Physical limitations (e.g., restricting injuries of the musculoskeletal system, or dependent of a third person).
- Exercise-related dyspnoea or respiratory alterations.
- Chronic heart disease with any worsening in the last month.
- Adherence rate of less than 80% of the total interventions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active comparator
Control group with obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
Other Names:
|
Experimental: Experimental group with morbid obesity
Experimental group with morbid obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting glucose
Time Frame: Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
High density lipoprotein
Time Frame: Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
Systolic blood pressure and diastolic blood pressure
Time Frame: from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
Waist circumference
Time Frame: Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
Triglycerides
Time Frame: Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass index
Time Frame: Change from Baseline Body mass index at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass index at 20-weeks of Resistant Training
|
Body mass
Time Frame: Change from Baseline Body mass at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass at 20-weeks of Resistant Training
|
Total cholesterol
Time Frame: Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
Low density lipoprotein
Time Frame: Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
Six minutes walking test
Time Frame: Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
Endurance performance
|
Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
One maximum repetition of biceps curl
Time Frame: Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
Strength Performance
|
Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
Handgrip muscle strength
Time Frame: Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
Muscle strength
|
Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Cristian ALvarez, PhD, Universidad de Los Lagos
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RP08042019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Behavioral
-
Summa Health SystemCompletedHypertension | Diabetes Mellitus | Pulmonary Disease, Chronic Obstructive | Osteoarthritis | Atrial Fibrillation | Osteoporosis | Coronary Arteriosclerosis | Cerebrovascular Accident | Heart Failure, Congestive
-
Roswell Park Cancer InstituteCompletedColorectal Cancer | Healthy, no Evidence of DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingHealthy SubjectUnited States
-
Mayo ClinicJames and Esther King Biomedical Research ProgramCompletedfor Cigarette Smoking and Binge Drinking CessationUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of RochesterRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Enrolling by invitationHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterCompletedCancer Survivor | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC...United States
-
Consorci Sanitari de TerrassaRecruitingCancer | Cognitive ImpairmentSpain
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingDiabetes Mellitus | Obesity-Related Malignant NeoplasmUnited States